Beyond the Coronary Artery: Analyzing the Dominance of CAD and the Pervasive Role of Stents in Peripheral Disease in the Balloon Expandable Stent Market
Description
This post segments the market based on medical application, detailing the significant revenue contribution from Coronary Artery Disease treatment and the growing use in Peripheral Artery Disease.
The Balloon Expandable Stent Market is segmented into several key applications, with Coronary Artery Disease (CAD) treatment holding the dominant share. CAD applications, including the treatment of blocked or narrowed coronary arteries, were valued at a substantial $2.1 billion in 2023 and are projected to reach $2.85 billion by 2032. This dominance is due to the high volume of PCI procedures performed globally.
However, the treatment of Peripheral Artery Disease (PAD) is also a pivotal and rapidly expanding segment, valued at $1.8 billion in 2023 and expected to reach $2.45 billion by 2032. Balloon expandable stents are increasingly favored for PAD in vessels like the iliac and renal arteries, where their precise placement and radial strength are highly beneficial. A smaller but important application is in Valve Replacement procedures, particularly Transcatheter Aortic Valve Replacement (TAVR), which also utilizes these stent platforms.